Recross Cardio

CompanyUnited States

Recross Cardio develops one asset, in human trials (PFO Sealing System in patent foramen ovale). Mostly device; based in the United States.

1
Asset
Furthest stage: Human trials; 0
Trials: 0
Signals

Pipeline

1

PFO Sealing System
Membrane-based catheter system designed for sealing patent foramen ovale septal defects.
Human trials, Device, patent foramen ovale

Full company profiles: pipeline, trials, funding and people.

In the full profile

Similar companies1